[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.169.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 1996

Pars Plana Vitrectomy in the Management of Phakic and Pseudophakic Malignant Glaucoma

Author Affiliations

From the Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami School of Medicine, Miami, Fla. Dr Harbour is now with the Department of Ophthalmology and Visual Sciences, Washington University School of Medicine and the Barnes Retina Institute, St Louis, Mo.

Arch Ophthalmol. 1996;114(9):1073-1078. doi:10.1001/archopht.1996.01100140275003
Abstract

Objective:  To determine the indications for and out-come of pars plana vitrectomy in the management of phakic and pseudophakic malignant glaucoma.

Design:  Retrospective review.

Setting:  Tertiary referral ophthalmic hospital.

Patients:  Twenty-two patients (24 eyes) who underwent pars plana vitrectomy in the management of malignant glaucoma.

Results:  Fourteen eyes were phakic and 10 were pseudophakic at the initial vitrectomy. The primary indication for vitrectomy was failure of other therapies. In phakic eyes, the initial vitrectomy was successful in terminating malignant glaucoma without further surgery in 7 (100%) of 7 eyes that underwent lensectomy and in 5 (71%) of 7 eyes that not did not undergo lensectomy. The primary indication for lensectomy was corneal edema caused by lens-corneal touch. In pseudophakic eyes, the initial vitrectomy was successful in 9 (90%) of 10 eyes. Removal of the intraocular lens was performed in 1 eye. Perioperative complications included transient serous choroidal detachment in 2 eyes, transient exudative retinal detachment in 1 eye, and suprachoroidal hemorrhage in 1 eye.

Conclusions:  Pars plana vitrectomy is effective in treating phakic and pseudophakic malignant glaucoma. Success is contingent on establishing a pathway for aqueous flow into the anterior chamber, which usually is accompanied by intraoperative deepening of the anterior chamber. In phakic eyes, lensectomy may be considered for marked corneal edema, for dense cataract, or when the anterior chamber will not deepen during vitrectomy.

References
1.
Simmons RJ, Belcher CD, III, Dallow RL.  Primary angle-closure glaucoma . In: Tasman W, Jaeger EA, eds. Duane's Clinical Ophthalmology . Philadelphia, Pa: JB Lippincott; 1985;3:23-31.
2.
Tomey KF, Traverso CE.  The glaucomas in aphakia and pseudophakia . Surv Ophthalmol . 1991;36:79-112.Article
3.
Lippas J.  Mechanics and treatment of malignant glaucoma and the problem of the flat anterior chamber . Am J Ophthalmol . 1964;57:620-627.
4.
Schwartz A, Anderson D.  'Malignant glaucoma' in an eye with no antecedent operation or miotics . Arch Ophthalmol . 1975;93:379-381.Article
5.
Luntz MH, Rosenblatt M.  Malignant glaucoma . Surv Ophthalmol . 1987;32:73-93.Article
6.
Reiser JC, Schwartz B.  Miotic-induced malignant glaucoma . Arch Ophthalmol . 1972;87:706-712.Article
7.
Cashwell LF, Martin TJ.  Malignant glaucoma after laser iridotomy . Ophthalmology . 1992;99:651-658.Article
8.
Mastropasqua L, Ciancaglini M, Carpineto P, Lobefalo L, Gallenga PE.  Aqueous misdirection syndrome: a complication of neodymium:YAG posterior capsulotomy . J Cataract Refract Surg . 1994;20:563-565.Article
9.
Hardten DR, Brown JD.  Malignant glaucoma after Nd:YAG cyclophotocoagulation . Am J Ophthalmol . 1991;111:245-247.
10.
Tomey KF, Senft SH, Antonios SR, Shammas IV, Shihab ZM, Traverso CE.  Aqueous misdirection and flat chamber after posterior chamber implants with and without trabeculectomy . Arch Ophthalmol . 1987;105:770-773.Article
11.
Melamed S, Cahane M, Gutman I, Blumenthal M.  Postoperative complications after Molteno implant surgery . Am J Ophthalmol . 1991;111:319-322.
12.
Levene R.  A new concept of malignant glaucoma . Arch Ophthalmol . 1972;87:497-506.Article
13.
Weiss DI, Shaffer RN.  Ciliary block (malignant) glaucoma . Trans Am Acad Ophthalmol Otolaryngol . 1972;76:450-461.
14.
Shaffer R.  Role of vitreous detachment in aphakic and maligant glaucoma . Trans Am Acad Ophthalmol Otolaryngol . 1954;58:217-231.
15.
Little BC, Hitchings RA.  Pseudophakic malignant glaucoma: Nd:YAG capsulotomy as a primary treatment . Eye . 1993;7:102-104.Article
16.
Melamed S, Ashkenazi I, Blumenthal M.  Nd-YAG laser hyaloidotomy for malignant glaucoma following one-piece 7 mm intraocular lens implantation . Br J Ophthalmol . 1991;75:501-503.Article
17.
Weber A.  Die Ursache des Glaucoms . Graefes Arch Ophthalmol . 1877;23:1-91.Article
18.
Chandler PA.  Malignant glaucoma . Am J Ophthalmol . 1951;34:993-1000.
19.
Chandler PA.  A new operation for malignant glaucoma: a preliminary report . Trans Am Ophthalmol Soc . 1964;62:408-424.
20.
Chandler PA, Simmons RJ, Grant WM.  Malignant glaucoma: medical and surgical treatment . Am J Ophthalmol . 1968;66:495-502.
21.
Lynch MG, Brown RH, Michels RG, Pollack IP, Stark WJ.  Surgical vitrectomy for pseudophakic malignant glaucoma . Am J Ophthalmol . 1986;102:149-153.Article
22.
Weiss H, Shin DH, Kollarits CR.  Vitrectomy for malignant (ciliary block) glaucomas . Int Ophthalmol Clin . 1981;21:113-119.Article
23.
Byrnes GA, Leen MM, Wong TP, Benson WE.  Vitrectomy for ciliary block (malignant) glaucoma . Ophthalmology . 1995;102:1308-1311.Article
×